Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-type calcium channel Cav3.2 subunit is a low-voltage activated, voltage-dependent calcium channel encoded by the CACNA1H gene. It comprises a pore-forming α1H subunit and serves as the principal molecular entity responsible for transient, low-threshold calcium currents in excitable cells, including neurons and cardiac pacemaker cells. Cav3.2 regulates the initiation and propagation of electrical signals, contributing to neuronal firing, neurotransmitter release, pacemaker activity, and sleep-wake oscillations. Cav3.2 is considered a promising therapeutic target for epilepsy and pain by virtue of its pivotal role in cellular excitability, with structure-based drug discovery ongoing for selective modulators. Dysfunction of Cav3.2 is implicated in neurological, cardiac, and sensory disorders, although current pharmacological agents have significant limitations, including selectivity and safety concerns.
Inhibition/blockade of the channel pore, preventing Ca²⁺ influx; State-dependent modulation (some ligands preferentially bind when the channel is open/inactive); Modulation of channel gating via phosphorylation or protein-protein interactions; Potential indirect modulation by G protein-coupled receptor signaling
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-type calcium channel subunit alpha-1H (commonly referred to as CaV3.2) (CaV3.2).